Precision Medicine: Oncology and Cardiovascular

Precision Medicine in Oncology is doled out to illuminating, instructing, and encouraging the trading of clinically pertinent data with respect to the disclosure and utilization of new Drug regimens, Molecular biomarkers, Cancer genomics, The goal of the Personalized Medicine in cardiac research is to stimulate understanding of promising new essential examination disclosures for the treatment of heart disillusionment and arrhythmias through especially formed clinical trials that display suitability and security. Cardiovascular revamping suggests the changes in estimate, shape, structure and physiology of the heart after harm to the myocardium. The mischief is regularly a direct result of extraordinary myocardial dead tissue. To depict the development in lipoprotein translation by hypothyroidism, adipocytes were prepared from control and hypothyroid rats. While LPL mix was higher in hypothyroid adipocytes, with no modification in mRNA levels, there was no extension in hormone-delicate lipase (HSL) mix

  • hematologic malignancies
  • Cardiovascular revamping
  • myocardial

Related Conference of Precision Medicine: Oncology and Cardiovascular

November 22-23, 2024

4th International Conference on Medical Research and Development

Aix-en-Provence, France
November 25-26, 2024

10th World Congress on Anesthesia and Critical Care

Paris, France
April 16-17, 2025

9th International Conference on Internal Medicine

Berlin, Germany
May 12-13, 2025

19th International Conference on Obesity Medicine

Toronto, Canada
June 24-25, 2025

3rd Global Summit on HIV-AIDS and STDs

Chicago, USA
July 16-17, 2025

11th World Congress on Medicinal Plants and Marine Drugs

Aix-en-Provence, France
August 07-08, 2025

12th World Summit on Epilepsy and Bipolar Disorders

Paris, France

Precision Medicine: Oncology and Cardiovascular Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in